deltatrials
Completed PHASE1 NCT00004853

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults With Sarcoma Treated With Dose-Intensive Chemotherapy

Sponsor: National Cancer Institute (NCI)

Conditions Ewing's Sarcoma High-risk Sarcoma MPNST Rhabdomyosarcoma Synovial Sarcoma
Interventions Filgrastim Filgrastim-SD/01
Updated 23 times since 2017 Last updated: Nov 8, 2019 Started: Mar 3, 2000 Primary completion: May 20, 2009 Completion: May 20, 2009

Listed as NCT00004853, this PHASE1 trial focuses on Ewing's Sarcoma and High-risk Sarcoma and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 23 times since 2000, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

23 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Dec 2019 — Jan 2021 [monthly]

    Completed PHASE1

  5. Nov 2019 — Dec 2019 [monthly]

    Completed PHASE1

▶ Show 18 earlier versions

  1. Sep 2019 — Nov 2019 [monthly]

    Completed PHASE1

  2. Aug 2019 — Sep 2019 [monthly]

    Completed PHASE1

  3. Jul 2019 — Aug 2019 [monthly]

    Completed PHASE1

  4. Jun 2019 — Jul 2019 [monthly]

    Completed PHASE1

  5. May 2019 — Jun 2019 [monthly]

    Completed PHASE1

  6. Apr 2019 — May 2019 [monthly]

    Completed PHASE1

  7. Mar 2019 — Apr 2019 [monthly]

    Completed PHASE1

  8. Feb 2019 — Mar 2019 [monthly]

    Completed PHASE1

  9. Jan 2019 — Feb 2019 [monthly]

    Completed PHASE1

  10. Dec 2018 — Jan 2019 [monthly]

    Completed PHASE1

  11. Oct 2018 — Dec 2018 [monthly]

    Completed PHASE1

  12. Sep 2018 — Oct 2018 [monthly]

    Completed PHASE1

  13. Aug 2018 — Sep 2018 [monthly]

    Completed PHASE1

  14. Jul 2018 — Aug 2018 [monthly]

    Completed PHASE1

  15. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE1

  16. May 2018 — Jun 2018 [monthly]

    Completed PHASE1

  17. Feb 2017 — May 2018 [monthly]

    Completed PHASE1

  18. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Mar 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bethesda, United States